chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At the time of the injection, the patient felt as though it was not right because her muscle instantly burned. A month later, her shoulder is aching and in severe pain. She cannot sleep at night and has never had any pain in her left shoulder in the past. She is considering seeking medical attention to address these concerns.
Allergic Skin Reaction: Moderate-severe pruritic maculo-papular rash present on bilateral hands including 100% finger and palm involvement and ~20% dorsum of hand. Rash extends on anterior arm up to axilla. Rash also present in inguinal area and 100% of buttocks and extends down posterior leg down to knee. Petechiae present bilaterally on ventral hands hand finger tips (likely related to squeezing hands for itch relief)  Rash was present around 60 hours after vaccination starting on buttocks and inguinal area and progressed to hands then armpits over the following day. Rash progressing in severity despite 50 mg oral Benadryl q6h, 40 mg oral prednisone daily, and topical hydrocortisone. Rash still present and progressing and no peak severity has been identified yet.
Rec'd VZV to right thigh 8/31/2011 3-4 d following - had increasing swelling redness at site.
Next morning (7am) sweating, nauseous, blurred and double vision, and dizziness   Went back to bed for about 2 hours and woke up with slight dizziness. Sweats and nausea were gone
Patient rec'd Gardasil #1 in (L) upper arm. She immediately c/o tingling and slight numbness going down her arm and became very lightheaded.
pt recvd vax 12JUN95 & 19JUN95 pt devel red papular rash on wrist, arms & abd; 02JUL95 pt dx w/scabies & tx w/Permethrin;pt recovered;
Diarrhea, nausea, dehydration, loss of weight, weakness, loss of appetite. On May 31, 2017, my husband went to the hospital for his annual checkup. At that time his primary care doctor commented that he was in very good shape for an 83 year old man. Then he gave him a pneumonia shot, PREVNAR 13. He said that it might make him a little sick but that would go away. Within a day or so he began feeling bad, threw up every thing he ate, got severe diarrhea and got very weak. Started getting dehydrated, and lost weight. We took him to the doctor again and he ran tests. The doctor was very surprised at how he looked. Even commented that he looked awful. Sent him home with some medication. But within a few days we took him back to the Emergency Room. They sent him home with medication. A few days later we took him to the emergency room again. And then to an other Emergency room. Still no results. Back to the hospital, and they were required to admit him They ran many tests. CT scan, MRI. Then one night he developed a heart problem (he never had any heart issues up till then). They moved him to another hospital. Cardiac ward. They did more tests and found that he had 2 massive strokes. He died on July 15, 2017. Up until the time he got that PREVNAR 13 shot he was a very healthy man. At 83 years old he could outwork a man 40 years old. He never had any heart issues. The most health problem he had was a prostate problem. Which he was being treated for. None of the doctors could find a reason for him being so sick. It all started with the shot that he was given on May 31. I would like some answers. What killed him? Was it the shot?
Hives-temp 104-received vaccines at 0900am and became ill at 2:30pm-required overnight stay in hospital.
Fever (102.5F at one point) and chills 6 hours after injection and continuing for a day, headaches, slight nausea, body and joint aches
Experiencing dizziness that was mild at first and barely noticeable to more serve the 3rd day
pt recvd vax 11MAY92 & 23MAY92 exp jaw pain, swollen hands & fingers, wrist pain & neck pain; sx persisted for 9 days x/pain in wrist;
sick, didn't feel good; sick, didn't feel good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A 44 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Apr2021 (Batch/Lot number: unknown, Expiration Date: 16Jul2021) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), MALAISE (non-serious) all with onset 16Apr2021, outcome "recovered" (2021) and all described as "sick, didn't feel good".  Additional Information: The reporter explained it was right after the shot and he was not sure what time the event occurred. He said patient got better a couple days later and recovered completely. The reporter did not elaborate on what he meant by sick, was not feeling good. History of all previous immunizations with the Pfizer vaccine considered as suspect, additional vaccines administered on same date, prior vaccinations within 4 weeks and adverse event prior vaccinations were none. The caller confirms that the patient missed her second dose which was scheduled on 07May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 68 year old female with a history of radiotherapy to breast 3 years ago who on 19-JUL-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (657765/0585U).  On 06-AUG-2007 the patient experienced left breast became red and vascular after she was given Zostavax (Oka/Merck).  Outcome of the patient is unknown.  No product quality complaint.  Additional information has been requested. 12/21/07 This is in follow-up to report(s) previously submitted on 9/24/2007. Follow-up information received from the physician on 05-Sep-2007 indicating that the patient received the vaccination in the left arm and also developed the AE of ecchymosis of the breast on the side of the vaccination, 1 to 2 weeks after the vaccination. All adverse events resolved on an unknown date in Aug-2007. The physician also reported an invalid lot# of 30370 (also reported previously as (657765/0585U). No further information is expected.
Mom states saw rash 21MAY92 on backarms, stomach then it went away; came back again all in same day, seen in ER MD gave Epi brought pt in had wheal small on chest & arms;
Clinic calls to report adverse reaction to Shingrix Vac he received on 15 JAN. States within 24 hours he broke out in all over body rash that resembled "chicken pox" that was very itchy for 3 days. Denies anaphylatic symptoms. He states today rash has resolved. Denies need to be seen.  I did give him VAERS phone number and notified that I am obligated to make a report in their database. He stayed on phone with me while I filled out online form.
Rash and swelling at injection site. Supportive therapy with ibuprofen, diphenhydramine, and ice to right shoulder.
Shortly after I got my vaccine, I felt tired. I thought it was due to the vaccine, but then I developed sneezing, runny nose, and a cough. On 11/21/2022, I had body aches, sore throat, cough, and nasal congestion. That morning, I took a home antigen test and got a positive result. I called the number for my medical provider and reported that I had just tested positive for COVID-19. On 11/22/2022, I was prescribed Paxlovid. I immediately started the medication. By 11/25/2022, I tested negative and felt fine. I completed the course of Paxlovid and felt fine afterwards.
superficial thrombophlebitis clot behind left knee; chills; headaches; This is a spontaneous report from a contactable consumer reporting for herself. A 36-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the Left Arm  on 13Apr2021 11:45 (Batch/Lot Number: Ew0162) as single dose for covid-19 immunisation  .  The patient medical history was not reported. Concomitant medication(s) included hydroxychloroquine (HYDROXYCHLOROQUINE) taken for an unspecified indication, start and stop date were not reported; sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported.  The patient experienced superficial thrombophlebitis clot behind left knee  on 14Apr2021 with outcome of recovering , chills  on 14Apr2021 with outcome of recovering , headaches  on 14Apr2021 with outcome of recovering.  The reported events were considered serious because caused the patient to visit  Emergency room/department or urgent care.  Follow up information has been requested. Lot number has already been provided.
pt recvd vax & had 8 cm erythema - hematoma; cellulitis at inject site;
The day after receiving her 2nd vaccine the patient was scheduled for a transfusion of packed red blood cells. During the transfusion the patient began to complain of nausea, headache, lower back pain and noted to have elevation in temperature 100.8.
15 days post vax pt devel fever, cough, rash & felt poorly;went on to devel sore throat;put on med;MD felt had the flu;
t105, glandular swelling, nasal congestion, red rash around mouth & chin?-duration: 7 days-elevated temp still present @ times; 91-2 per day) rash still evident 2MAR94;
pt recvd vax; exp pain in shoulder joint immediately p/ vax; could not abduct shoulder greater then 90degrees; no inject site rxn or arthralgias;afebrile; dx impingement type of synd; tx w/ non-steroidal anti-inflammatory med;
Site: Pain at Injection Site-Mild, Additional Details: Patient came into the pharmacy picking up his regular medication, while chatting about getting his second shingrix vaccine, he mentioned that he has been experiencing mild, non-debilitating, but noticeable discomfort on his left arm where the first injection occurred.  After talking to him, I suggested he should talk to his doctor during his next office visit in May to discuss if this was indeed an related to the shingrix vaccine.
6/7 Minute red spots on lower left leg.  6/8 Severe headache, dizziness, nausea lasted 3 days 6/14 Raised rash on lower left arm and lower left leg observed 6/15 Started OTC Benadryl oral and topical rash becoming more apparent and raised on left extremities itchy and painful 8/16 Continued with Benadryl  oral and topical  - no relief 8/17 Rash noticed on Right upper arm - maintained Benadryl  - no relief 8/18 Called Physician - Video conference - Reported Symptoms and no changes to diet, detergents or environment after taking 1st dose of Pfizer on 6/4/2021 - Prescribed Cephlexin and OTC anti fungal topical. 8/19 and 8/20 - Rash appeared on right lower leg, Rash maintained on all other extrimites. Blisters started to form on rash effected areas/ 8/21 Visited Physician perscribed Valtrex, Docycycline and Pednisone. Give  steriod shot in office.  8/22 to present - All affected area's are covered in blisters that are oozing clear fluid. Progression of rash has stopped presently. No fever, dizziness or headache.
t102 responded to APAP, inject site of (DTP) red, hot, swollen; On 8JUN91 devel silver dollar size, whelps on legs which then spread over body; c/o itching; no dyspnea; Seen by MD 9JUN91 given DPH & told fluid behind lt ear;
05/14/2022 I had my second booster. On 08/03/2022 I started experience I was getting a really bad sinus headache. I thought I had a cold. Tested COVID negative that Tuesday night on 08/02/2022. On the morning of 08/03/2022 I tested positive. I was put on 3 pills 2 times a day PAXLOVID. Physically I feel fine but my lung capacity I am still working on and producing phlegm.
ToNguE on Left SIDE Became tender an swollen INcreAsed pAIN some RedNess.
Fever of 100.5, chills, body aches, pain at shot site, brain fog
Fever ranging from 99.6 unto 100.6 noticed on 18th January and it has continued on the 19th.  Also had a headache.   Temperature is 100.5 at the time of writing this report.  Taken with Braun ear thermometer.  Asthma is aggravated and I have had to take my inhaler two times since the morning.  No other medication taken.  Had a sore throat this morning.  initially what made me check my temperature yesterday as I felt hot and light headed and felt I needed to sleep.  Slept for a few hours to regain energy.
rash; itching; swollen; sore; tired; warmth; red rash at site of injection; redness; swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (red rash at site of injection), INJECTION SITE WARMTH (warmth), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE RASH (rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A029L20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (water blisters on hands) since 1960, Allergy to antibiotic (cipro, sore muscles, tingling) since 2004, Allergy to antibiotic (tetracycline) since 1997 and Allergy to antibiotic (sulfa, red itching rash, head to toe) since 1963. Concomitant products included SIMVASTATIN (ZOCOR) for Hypercholesteremia, ZOLPIDEM TARTRATE (AMBIEN) for Sleep problem, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), MULTIVITAMINS & MINERALS PLUS LUTEIN, ZINC, VITAMIN D3, CYANOCOBALAMIN (VITAMINE B12), VITAMIN C [ASCORBIC ACID] and PANTOPRAZOLE for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE SWELLING (swelling). On 01-Feb-2021, the patient experienced HYPERSENSITIVITY (red rash at site of injection). On 03-Feb-2021, the patient experienced INJECTION SITE WARMTH (warmth), VACCINATION SITE RASH (rash), VACCINATION SITE PRURITUS (itching), INJECTION SITE SWELLING (swollen), MYALGIA (sore) and FATIGUE (tired). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency. On 27-Jan-2021, VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE SWELLING (swelling) had resolved. On 08-Feb-2021, HYPERSENSITIVITY (red rash at site of injection) had resolved. At the time of the report, INJECTION SITE WARMTH (warmth), VACCINATION SITE RASH (rash), VACCINATION SITE PRURITUS (itching), INJECTION SITE SWELLING (swollen), MYALGIA (sore) and FATIGUE (tired) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events were Not Applicable. No treatment drugs are not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Patient medical history was updated, New adverse event - hypersensitivity reaction was updated,Second dose information was updated.
2 days after vaccinated with DT and MMR, developed orange-sized lump, warm/red and tender at site of DT. Also fever to 102 degrees.
Information has been received from a pharmacist concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL (dose, route and lot number not reported). The pharmacist reported that patient received one or two doses of GARDASIL, experienced a 104F temperature. The patient sought unspecified medical attention. Additional information has been requested.
Patient received the Janssen covid vaccine, which is indicated for 18 and older persons. Patient was monitored for 15-20 minutes and followed up with after a few days. She reported no issues
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/25/2021 and 3/17/2021. Presented to another organizations ED on 8/7/2021 with complaints of hematuria in Foley bag, and pain in lower part of abdomen. Patient was subsequently found to have COVID infection that was asymptomatic (on room air throughout admission) and discharged on 8/12/2021. Patient subsequently presented to ED on 8/26/2021 with generalized weakness and altered mental status. Patient's mentation briefly improved with supplemental oxygen. Chest X-ray Atelectasis/infiltrate especially left mid and lower lung zones, clinical correlation recommended for developing acute pneumonia/pneumonitis. CT Chest shows occlusive and non occlusive PE  LUL, small bilat eff, bilat lower lobe consolidation. In ER patient was noted to be in atrial fibrillation with RVR and was initiated on cardizem. Patient was diagnosed with severe sepsis, bilateral pneumonia, and UTI from indwelling foley (Candida albicans), Pulmonary embolism, hypernatremia, as well as continued COVID positive originally diagnosed 8/7/2021 and confirmed with repeat testing on 8/26/2021.  Patient was transitioned to inpatient hospice on 8/30/2021, and expired on 9/5/2021.
About 12 hours later came down with severe chills fever. They persisted for over two days at the time of this I still have fever. I did treat my symptoms with over-the-counter pain medication. Advil. My high temperature was nearly 103°
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 16-APR-2012, the patient was inoculated with ZOSTAVAX from her primary care physician at that time for routine health maintenance and for the prevention of shingles. The vaccine did not prevent shingles, but rather caused the patient to contract a persistent and severe strain of herpes zoster. In approximately 2012 (reported as "shortly after" receiving ZOSTAVAX), the patient began to experience burning sensations near her hip and stomach. In response to these complaints, the patient presented to the same physician and was diagnosed as suffering from internal shingles and "posthepatic" (considered to mean post herpetic) neuralgia. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events were not recovered/not resolved (lawyer reported that currently, the patient continued to suffer from the effects of internal shingles and "posthepatic" neuralgia). Causality assessment was considered related. Additional information has been requested.
At injection site there is a bump; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (At injection site there is a bump) and HEADACHE (Slight headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: FLU SHOT (2 weeks ago in the same arm where booster vaccine given.) in October 2021. Past adverse reactions to the above products included No adverse event with FLU SHOT.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, the patient experienced VACCINATION SITE NODULE (At injection site there is a bump) and HEADACHE (Slight headache). At the time of the report, VACCINATION SITE NODULE (At injection site there is a bump) and HEADACHE (Slight headache) had not resolved.            No concomitant medications were reported.   No treatment information was reported.    Reporter did not allow further contact
Extremely sore arm, beginning only several minutes after injection, persisting at least several several hours and days, painful to move, difficult to use for normal tasks Fatigue, sleepiness,
Possible blood clots; Numbness in tips of pinky finger and the finger beside it; Soreness at the injection site; States two days after that he felt soreness in his arm; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received BNT162B2 (COMIRNATY), via an unspecified route of administration, administered in left arm on 21Sep2021 15:30 (at the age of 45-year-old) (Lot Number: EWB161) as dose 1, single for COVID-19 immunization. Medical history included ongoing kidney cancer (diagnosed a year or two years ago and they went in and cut it out). Concomitant indications included none. Prior Vaccinations (within 4 weeks) were none. Two days after vaccination, patient felt soreness in his arm. The patient stated that two days after that on Monday or Tuesday of the next week. The patient stated his pinky finger was now feeling numb and the finger beside it also and the numbness was not going away; The patient stated if he felt this numbness and had just woken up then he would not be upset but it was now 15:30 and he has been up all day and still felt the numbness in his fingertips and it was concerning (patient stated that normally if he was asleep and when he slept on arms, his arms would get numb and the patient would wake up and move). The patient stated he was feeling some type of way and used his other hand to keep rubbing his fingers to get blood flow to it. The patient also said that he had soreness at the injection site and was good to go on that and could take a punch in the arm and it would not be sore. The outcome of injection site soreness and soreness in arm was recovered. The outcome of numbness was not recovered and the outcome of other event was unknown.   Follow-up attempts are completed. No further information is expected.
Fever; fatigue, headache, scalp sensitivity (for 1 week after 11-21-2021); body aches and general unease. Received intravenous steroid shot and tylenol at Hospital Emergency Room after blood tests, x-ray and CT scan. Referred to Dr.  Hospital. Began predinisone which controlled fever and fatigure, but was discontinued after 3 weeks. Referred to Dr.  Hospital for ultrasound scan and biopsy which excluded giant cell arteritis. Referred to Dr.  for infectious disease blood panels and tests. CT, MRI PET scans and colonoscopy  excluded possibility of cancer.  Rheumatological diseases excluded. Fever and fatigue continue to. controlled by tylenol (250 mg every 8 hours. Attempt to extend time between doses results in r=increase in body ache/pain and fever.
Low grade fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) and HEADACHE (Headache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS], ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, PROPRANOLOL, VITAMIN D3, DULOXETINE HCL, IBUPROFEN (MOTRIN [IBUPROFEN]), CLONAZEPAM (KLONOPIN), CEFIXIME (FLEXERIL [CEFIXIME]), DICLOFENAC SODIUM (PENNSAID), PREGABALIN, ZOLPIDEM TARTRATE (AMBIEN), LIDOCAINE, CALCIUM, MELATONIN, VITAMIN B NOS (B-COMPLEX [VITAMIN B NOS]), EZETIMIBE (ZETIA), SOLIFENACIN SUCCINATE (VESICARE), ASCORBIC ACID (VITAMIN C ACID) and LORATADINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache). On 26-Mar-2021, the patient experienced PYREXIA (Low grade fever). At the time of the report, PYREXIA (Low grade fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Body temperature decreased: (Low) Body temperature is lower than normal.. On 26-Mar-2021, Pyrexia: 99.1 (Low) Lowgrade fever in 99.1Fs.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided.  No treatment information was provided.